[1]Hayes DF.Clinical practice Follow-up of patients with early cancer [J] . N Engl Med,2007,356(24):2505-2513.
[2]曾 华,于 颖.乳腺癌患者心理分析及护理对策[J].当代护士,2007,9:85.
[3]高 睿,李小妹.信息支持对乳腺癌术后心理状态的影响[J].护理研究,2007,21(4):874-876.
[4]何朝霞.乳腺癌的心理分析及护理 [J].全科护理,2011,8(12):3155.
[5]周作枝. 青年乳腺癌治疗探讨 [J].临床医学,2010,23(12):66.
[6]许 丽,宛翠秀,郑桂芝. 阶段性个性化健康教育对乳腺癌根治术患者的效果评价 [J].东南国防医药,2008,10(2):116-117.
[1]邵明永,丁庆莉,高 纯,等.CA125和CA153联合检测对乳腺癌的诊治价值[J].医学研究与战创伤救治(原医学研究生学报),2013,15(05):433.[doi:10.3969/j.issn.1672-271X.2013.05.001]
SHAO Ming-yong,DING Qing-li,GAO Chun,et al.Roles of detection of CA125 and CA153 in diagnosis and therapy of breast cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(06):433.[doi:10.3969/j.issn.1672-271X.2013.05.001]
[2]杜庆安,丁蓉蓉,蔡 凯,等.HER-2多肽负载自体树突状细胞治疗HER-2阳性乳腺癌的初步研究[J].医学研究与战创伤救治(原医学研究生学报),2013,15(06):581.[doi:10.3969/j.issn.1672-271X.2013.06.009]
DU Qing-an,DING Rong-rong,CAI Kai,et al.The primary effect of vaccination with autologous dendritic cells loaded with Her-2 peptides against Her-2 positive breast cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(06):581.[doi:10.3969/j.issn.1672-271X.2013.06.009]
[3]朱成宾,潘玉琴,何帮顺.微小RNA多态性与中国女性人群乳腺癌发病及病理特征的相关性研究[J].医学研究与战创伤救治(原医学研究生学报),2015,17(01):22.[doi:10.3969/j.issn.1672-271X.2015.01.007]
ZHU Cheng-bin,PAN Yu-qin,HE Bang-shun..Study on the association of polymorphisms in microRNAs and risk of breast cancer and its clinic pathological parameters[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(06):22.[doi:10.3969/j.issn.1672-271X.2015.01.007]
[4]刘 彧,童清平,连 娟,等.乳腺癌弹性超声特征与分子生物学指标的相关性研究[J].医学研究与战创伤救治(原医学研究生学报),2015,17(02):116.[doi:10.3969/j.issn.1672-271X.2015.02.002]
LIU Yu,TONG Qing-ping,LIAN Juan,et al.Relationship between ultrasonic elastography features and ER, PR, Her-2 and Ki67 expression in molecular biology of breast[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(06):116.[doi:10.3969/j.issn.1672-271X.2015.02.002]
[5]陈涛,王璇,程凯,等.CD47在乳腺癌及癌旁组织中的表达及其意义[J].医学研究与战创伤救治(原医学研究生学报),2018,20(05):501.[doi:10.3969/j.issn.1672-271X.2018.05.012]
CHEN Tao,WANG Xuan,CHENG Kai,et al.Expression and significance of CD47 in breast cancer and pericancerous tissues[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(06):501.[doi:10.3969/j.issn.1672-271X.2018.05.012]
[6]陈雨秋,周国华,顾军.半乳糖凝集素3与乳腺癌的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2020,22(5):510.[doi:10.3969/j.issn.1672-271X.2020.05.013]
CHEN Yu-qiu,ZHOU Guo-hua,GU Jun.Research progress of galectin-3 and breast cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(06):510.[doi:10.3969/j.issn.1672-271X.2020.05.013]
[7]地里呼玛尔·吐鲁洪,李欣芳,王少华.HR+/HER2-乳腺癌内分泌治疗的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2021,23(04):387.[doi:10.3969/j.issn.1672-271X.2021.04.011]
Dilihumaer Tuluhong,LI Xin-fang,WANG Shao-hua.The trend of endocrine therapeutic approach in HR+/HER2-breast cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(06):387.[doi:10.3969/j.issn.1672-271X.2021.04.011]
[8]何小芳,周敏,熊朝月,等.乳腺癌超声征象及其术后复发的危险因素分析[J].医学研究与战创伤救治(原医学研究生学报),2022,24(3):274.[doi:10.3969/j.issn.1672-271X.2022.03.011]
HE Xiao-fang,ZHOU Min,XIONG Chao-yue,et al.Ultrasonicsigns of breast cancer and analysis of risk factors for postoperative recurrence[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2022,24(06):274.[doi:10.3969/j.issn.1672-271X.2022.03.011]
[9]吴勤研,蓝晓红,吴波,等.基于生物信息技术分析人参皂苷防治乳腺癌的作用机制[J].医学研究与战创伤救治(原医学研究生学报),2022,24(3):282.[doi:10.3969/j.issn.1672-271X.2022.03.013]
WU Qin-yan,LAN Xiao-hong,WU Bo,et al.Analysis of the mechanism of action of ginsenosides in preventing and treating breast cancer based on bioinformatics technology[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2022,24(06):282.[doi:10.3969/j.issn.1672-271X.2022.03.013]
[10]林慧,陈佳菁,郭志锋,等.miR-9-5p在乳腺癌组织中的表达与生物信息学分析[J].医学研究与战创伤救治(原医学研究生学报),2023,25(1):23.[doi:10.3969/j.issn.1672-271X.2023.01.005]
LIN Hui,CHEN Jiajing,GUO Zhifeng,et al.Expression and bioinformatic analysis of miR-9-5p in breast cancer tissues[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2023,25(06):23.[doi:10.3969/j.issn.1672-271X.2023.01.005]